| Product Name | MF | CAS | Details |
|---|
| 3-Methoxybenzyl chloride | C8H9ClO | 824-98-6 | Details |
| tert-Butyl 5-methylthiophene-2-carboxylate | C10H14O2S | 956502-03-7 | Details |
| 6-Amino-2-pyrazinecarboxylic acid | C5H5N3O2 | 61442-38-4 | Details |
| H-Gly-Gly-Gly-NH2·HCl | C6H12N4O3 | 35790-47-7 | Details |
| Debio-0827 | C22H34N2O6S3 | 935481-06-4 | Details |
| Guanosine-2'(&3')-monophosphate disodium (mixed isomers) | C10H12N5Na2O8P | 6027-83-4 | Details |
| HSV2 gC antibody | Details |
| 2-(2,4-Dihydroxyphenyl)-6-hydroxybenzofuran | C14H10O4 | 67736-22-5 | Details |
| 5-Hydroxy-3,4-dihydro-2(1H)-quinolinone | C9H9NO2 | 30389-33-4 | Details |
| Dictamnine | C12H9NO2 | 484-29-7 | Details |
| Ethyl eosin | C22H13Br4KO5 | 6359-05-3 | Details |
| 1-(4-Chlorophenyl)-5-(2-methoxyethoxy)-4-oxo-1,4-dihydrocinnoline-3-carboxylic acid | C18H15ClN2O5 | 130561-48-7 | Details |
| Ajugacumbin A | C27H38O7 | 124961-66-6 | Details |
| 5-Bromo-1-ethyl-3-methyl-1,2-dihydropyridin-2-one | C8H10BrNO | 916344-85-9 | Details |
| 4-Chloro-7-(2-deoxy-3,5-bis-O-(p-toluoyl)-b-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine | Details |
| 3-(3-Fluoro-4-methoxyphenyl)propanal | C10H11FO2 | 1036396-31-2 | Details |
| (1S,3S,5S)-2-tert-Butyl 3-ethyl 2-azabicyclo[3.1.0]hexane-2,3-dicarboxylate | C13H21NO4 | 214193-11-0 | Details |
| Polystachoside | C20H18O11 | 5041-68-9 | Details |
| 1-(5-(Trifluoromethyl)pyridin-2-yl)ethanone | C8H6F3NO | 248274-16-0 | Details |
| methyl 5,6-dihydroxypyridine-3-carboxylate | C7H7NO4 | 1363382-77-7 | Details |
| (1S)-1-(4-tert-Butylphenyl)ethan-1-ol | C12H18O | 101325-14-8 | Details |
| Ethyl 4-hydroxy-8-methylquinoline-3-carboxylate | C13H13NO3 | 77156-75-3 | Details |
| 5'-O-DMT-N2-isobutyryl-2'-O-methylguanosine | C36H39N5O8 | 114745-26-5 | Details |
| LysRs-in-2 | C17H16F3NO4 | 2170696-76-9 | Details |
| 2-(2,4-Dimethylthiazol-5-yl)ethanamine | C7H12N2S | 142437-68-1 | Details |
| N-Boc-L-prolinol | C10H19NO3 | 69610-40-8 | Details |
| 4,6-O-Benzylidene-1,2,3-tri-O-pivaloyl-b-D-galactopyranose | C28H40O9 | Details |
| 4-(1-Cyano-1-methylethyl)-3-fluorobenzonitrile | C11H9FN2 | 1314741-25-7 | Details |
| 4-Nitrophenylmethylcarbinol | C8H9NO3 | 6531-13-1 | Details |
| 2-Cyclopropylpropan-1-amine hydrochloride | C6H14ClN | 1209286-56-5 | Details |
| SLC22A13 antibody | Details |
| C-Cyclopentyl-C-phenyl-methylamine hydrochloride | C12H18ClN | 24260-05-7 | Details |
| tert-Butyl 2-[ethyl(piperidin-4-yl)amino]acetate | C13H26N2O2 | 1184273-01-5 | Details |
| Olopatadine HCl - Bio-X ? | C21H24ClNO3 | 140462-76-6 | Details |
| 1-(1H-Indol-3-yl)-2-methylprop-2-en-1-one | C12H11NO | 91568-92-2 | Details |
| ADSL antibody | Details |
| rac-Lamivudine acid | C8H9N3O4S | 173602-25-0 | Details |
| 5-Chloro-4-(trifluoromethyl)pyrimidin-2-amine | C5H3ClF3N3 | 1805481-71-3 | Details |
| Sodium 2,3,5,6-Tetrafluoro-4-hydroxybenzenesulfonate | C6HF4NaO4S | 221908-17-4 | Details |
| Ethyl cyanoformate | C4H5NO2 | 623-49-4 | Details |
| Salbutamon hydrochloride | C13H20ClNO3 | 41489-89-8 | Details |
| Methyl[(4-methyl-1,3-thiazol-5-yl)methyl](pyrrolidin-3-ylmethyl)amine | C11H19N3S | 1409185-92-7 | Details |
| (Z)-4-(3-Bromo-5-ethoxy-4-((2-fluorobenzyl)oxy)benzylidene)-2-(thiophen-2-yl)oxazol-5(4H)-one | C23H17BrFNO4S | 445250-00-0 | Details |
| Reduced nicotinamide riboside | C11H16N2O5 | 19132-12-8 | Details |
| 5-[(4-Methylphenyl)methyl]-1,3-thiazol-2-amine | C11H12N2S | 299953-94-9 | Details |
| KIRREL2 Blocking Peptide | Details |
| 4-bromo-1H-pyrrolo[2,3-b]pyridin-6-amine | C7H6BrN3 | 943323-55-5 | Details |
| Nitrofurazone-BSA | Details |
| 2-(4-Methylpiperidin-1-yl)-5-(trifluoromethyl)aniline | C13H17F3N2 | 445465-72-5 | Details |
| 1-Bromo-2-fluoro-4-(methoxymethoxy)benzene | C8H8BrFO2 | 1054314-58-7 | Details |
| 6-chloro-2,5-dimethylpyrimidin-4-amine | C6H8ClN3 | 18260-92-9 | Details |
| 8-Chloro-6-fluoroquinoline | C9H5ClFN | 22319-88-6 | Details |
| 5-Methyl 7-methoxyisoflavone | C17H14O3 | 82517-12-2 | Details |
| 6,8-Dichloro-1,2,3,4-tetrahydroisoquinoline hydrochloride | C9H10Cl3N | 73075-50-0 | Details |
| GORASP2 antibody | Details |
| 3,6,7,11-Tetramethyldodeca-2,6,10-trien-1-ol | 2229683-14-9 | Details |
| 5-(3-Cyanophenyl)-1,2,4-oxadiazole-3-carboxylic acid | C10H5N3O3 | 1342223-83-9 | Details |
| trans-2-[3-(4-tert-Butylphenyl)-2-methyl-2-propenylidene]malononitrile | C17H18N2 | 300364-84-5 | Details |
| 3-Methyl-5-(trifluoromethyl)-1H-indole-2-carboxylic acid | C11H8F3NO2 | 854531-37-6 | Details |
| Recombinant Human Fas Ligand (FasL) | Details |
| 3-(4-Chlorophenyl)-2-methyl-3,4-dihydroquinazolin-4-one | C15H11ClN2O | 1788-93-8 | Details |
| Bicinchoninic Acid Kit for Protein Determination for 200-1000 μg/ml protein | Details |
| Thyroxine-HRP | Details |
| IDI1 protein (His tag) | Details |
| SB-200646A | C15H14N4O.ClH | 143797-62-0 | Details |
| 1-(3-Hydroxyphenyl)pyrrolidine-2,5-dione | C10H9NO3 | 1204-36-0 | Details |
| 3,4-Diethyl-1H-pyrrole-2-carboxylic acid ethyl ester | C11H17NO2 | 97336-41-9 | Details |
| (4-Fluorooxan-4-yl)methanesulfonyl chloride | C6H10ClFO3S | 1803608-24-3 | Details |
| 4-[(Pyridin-3-yl)methoxy]aniline | C12H12N2O | 105350-44-5 | Details |
| Dynorphin A (1-10) amide | C57H92N20O11 | 79985-49-2 | Details |
| (+)-(3R)-3-{[tert-Butyl(dimethyl)silyl]oxy}dihydrofuran-2(3H)-one | C10H20O3Si | 669000-31-1 | Details |
| 2-Ethoxy-5,7-diazaspiro[3.4]octane-6,8-dione | C8H12N2O3 | 1695771-59-5 | Details |
| alpha Synuclein A30P protein | Details |
| [(2-Methoxyethyl)carbamoyl]formic acid | C5H9NO4 | 80638-54-6 | Details |
| 1-Cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazole-5-carboxylic acid | C13H14N2O3 | 846562-87-6 | Details |
| N-(2-methoxy-5-nitrophenyl)-1-phenylcyclopentane-1-carboxamide | C19H20N2O4 | 627056-98-8 | Details |
| 4-(Aminomethyl)-5,5-dimethylpyrrolidin-2-one | C7H14N2O | 2241129-97-3 | Details |
| TentaGel??Microsphere NH2 Resin (30 um) | Details |
| Desmethylnortriptyline hydrochloride | C18H20ClN | 25887-71-2 | Details |
| 5-tert-Butylpiperidin-2-one | C9H17NO | 65970-69-6 | Details |
| H-Lys-Gly-Gly-OH hydrochloride salt | C10H20N4O4 | 55488-08-9 | Details |
| 2-{[4-(4-Chlorophenyl)-5-(4-methoxyphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetohydrazide | C17H16ClN5O2S | 893726-54-0 | Details |
| Benzyl[3-(dimethylamino)propyl]amine dihydrochloride | 22102-29-0 | Details |
| OR2M5 antibody | Details |
| H-ERSPVIQTL-OH | Details |
| VOPP1 antibody (HRP) | Details |
| Zymosan | 9010-72-4 | Details |
| 4-Carbamoyl-2-[(4-chlorophenyl)formamido]butanoic acid | C12H13ClN2O4 | 1396963-68-0 | Details |
| 1-(1-Methyl-1H-pyrazol-4-yl)-2-phenylethan-1-ol | C12H14N2O | 1247489-83-3 | Details |
| 5-(Pyridin-2-yl)-1,3,4-thiadiazol-2-amine | C7H6N4S | 25468-22-8 | Details |
| HIV1 tat antibody (FITC) | Details |
| 5-(Methoxycarbonyl)bicyclo[3.1.0]hexane-1-carboxylic acid | C9H12O4 | 25090-43-1 | Details |
| 2-Bromo-N-(3-tert-butyl-1,2-oxazol-5-yl)acetamide | C9H13BrN2O2 | 92944-37-1 | Details |
| 3-[4-Chloro-3-(trifluoromethyl)phenyl]-1-(4-chlorophenyl)urea | C14H9Cl2F3N2O | 369-77-7 | Details |
| N,N-Dimethylmorpholine-3-carboxamide hydrochloride | C7H15ClN2O2 | 1101822-35-8 | Details |
| Poly(2'-O-Methyladenosine 5'-monophosphate) sodium | C11H16N5O7P | 28516-86-1 | Details |
| (1-Methanesulfinylcyclobutyl)methanamine | C6H13NOS | 1803583-27-8 | Details |
| tert-Butyl N-[(3-oxocyclohexyl)methyl]carbamate | C12H21NO3 | 1260836-35-8 | Details |
| 5-Methoxyflavanone | C16H14O3 | 123931-32-8 | Details |
| alpha beta TcR antibody | Details |
| Product Total： Product Page： | ||||
| 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 | ||||